Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,647 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption

NCT01069809

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: UCDavis Research Office at CARES Sacramento, California, United States

Jacobi & North Central Bronx Hospitals The Bronx, New York, United States

AIDS Clinical Trials Unit Chapel Hill, North Carolina, United States

Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users

NCT01161485

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Project Safe Denver, Colorado, United States

View Trial Details

Completed

Reducing HIV in Adolescents

NCT01187979

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Vulindlela Clinical Research Site Durban, KwaZulu-Natal, South Africa

View Trial Details

Completed

ART Drug Dosage Adjustment in HIV-infected Population

NCT02632474

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Shanghai Public Health Clinical Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

NCT01209065

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Buffalo, New York, United States

View Trial Details

Completed

A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176

NCT02715479

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Austin, Texas, United States

View Trial Details

Completed

Single and Repeated Dose Escalation Study of GSK2838232

NCT02795754

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations

NCT02738931

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Overland Park, Kansas, United States

View Trial Details

Completed

Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy

NCT02342223

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Sacramento VA Medical Center Mather, California, United States

View Trial Details

Completed

A Study to Evaluate the Effect of High Fat Meal on Cabotegravir

NCT02799264

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Overland Park, Kansas, United States

View Trial Details

Lentivirus Infections

Lentivirus Infections trial results

Related conditions